Increased CD271 expression by the NF-kB pathway promotes melanoma cell survival and drives acquired resistance to BRAF inhibitor vemurafenib

Specific BRAFV600E inhibitors (BRAFi) are highly effective in the treatment of melanoma. However, acquired drug resistances invariably develop after the initial response. Therefore, the identification of new mechanisms of acquired resistance gives important clues towards the development of therapies...

Descripción completa

Detalles Bibliográficos
Autores principales: Lehraiki, Abdelali, Cerezo, Michael, Rouaud, Florian, Abbe, Patricia, Allegra, Marilyne, Kluza, Jerome, Marchetti, Philippe, Imbert, Veronique, Cheli, Yann, Bertolotto, Corine, Ballotti, Robert, Rocchi, Stéphane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860830/
https://www.ncbi.nlm.nih.gov/pubmed/27462428
http://dx.doi.org/10.1038/celldisc.2015.30

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860830/
https://www.ncbi.nlm.nih.gov/pubmed/27462428
http://dx.doi.org/10.1038/celldisc.2015.30

Ejemplares similares